sodium fluoride has been researched along with Osteoporosis, Postmenopausal in 79 studies
Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the need for a randomised study of treatment of spinal osteoporosis with human parathyroid peptide in the secondary prevention of crush fractures; to study the effect of human parathyroid hormone peptide 1-34 plus sex hormones on vertebral body cancellous bone; and, separately, to determine the effect of relatively low doses of sodium fluoride plus calcium on spinal bone mineral density." | 7.68 | Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. ( Davies, UM; Hesp, R; Katz, D; McNally, E; Reeve, J, 1990) |
| "76 years, were treated in the course of one year with sodium fluoride (Fluosen) in a dose of 45 mg/24 h in combination with calcium gluconate (2 g/24 h) and oil solution of vit D2 (2 mg/week)." | 5.28 | [Treatment of patients with postmenopausal and steroid-induced osteoporosis using sodium fluoride combined with vitamin D2 and calcium gluconate]. ( Andreeva, M; Diankova, L; Kamenova, P; Khristova, D; Todorova, S; Tsachev, K, 1990) |
| "Long-term clinical effects of intermittent sodium fluoride (slow-release) therapy were assessed in 71 patients with primary osteoporosis." | 5.06 | Effect of intermittent therapy with a slow-release fluoride preparation. ( Pak, CY; Sakhaee, K; Zerwekh, JE, 1990) |
| "The use of sodium fluoride for treatment of osteoporosis has led to the arousal of particular complications: osteomalacia and cortical bone fractures which are enhanced by preexisting bone diseases." | 3.68 | [Bone complications of fluorotherapy: influence of androgen deficiency]. ( Aghassian, C; Hartemann, P; Leclère, J; Morel, J; Weryha, G, 1990) |
| "To evaluate the need for a randomised study of treatment of spinal osteoporosis with human parathyroid peptide in the secondary prevention of crush fractures; to study the effect of human parathyroid hormone peptide 1-34 plus sex hormones on vertebral body cancellous bone; and, separately, to determine the effect of relatively low doses of sodium fluoride plus calcium on spinal bone mineral density." | 3.68 | Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. ( Davies, UM; Hesp, R; Katz, D; McNally, E; Reeve, J, 1990) |
| "According to previous pharmacokinetic studies the bioavailability of fluorine (F) from sodium monofluorophosphate (MFP) doubles that of sodium fluoride (NaF)." | 2.69 | In postmenopausal osteoporosis the bone increasing effect of monofluorophosphate is not dependent on serum fluoride. ( Bocanera, R; Masoni, A; Morosano, M; Pera, L; Puche, RC; Rigalli, A; Tozzini, R, 1999) |
| "Etidronate was well tolerated." | 2.69 | Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3 year trial. ( Carbonell, J; Farrerons, J; Guañabens, N; Monegal, A; Pavesi, M; Perez-Edo, L; Renau, A; Roca, M; Torra, M, 2000) |
| "Sodium fluoride treatment of osteoporosis is known to stimulate bone formation and to increase bone mass, but recent clinical trials failed to prove its antifracture effectiveness." | 2.67 | Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle x-ray-scattering study. ( Abendroth, B; Eschberger, J; Fratzl, P; Klaushofer, K; Roschger, P, 1994) |
| "110 patients with postmenopausal osteoporosis were randomly assigned to two groups." | 2.67 | Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial. ( Adams-Huet, B; Boyd, P; Breslau, NA; Haynes, S; Heard-Sakhaee, A; Herzog, J; Pak, CY; Peterson, RD; Piziak, V; Poindexter, JR; Reisch, JS; Sakhaee, K, 1994) |
| " Because during the 4 year trial the NaF dosage was decreased (because of side effects) in 54 of the 101 women randomized to NaF, dose-response relationships could be evaluated." | 2.67 | Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis. ( Chao, E; Hodgson, SF; Lane, A; Melton, LJ; Muhs, J; O'Fallon, WM; Riggs, BL; Wahner, HW, 1994) |
| " As the bioavailability of sodium fluoride (NaF) can be impaired by concomitant absorption of calcium, both drugs have to be ingested separately." | 2.67 | Bioavailability of fluoride in postmenopausal women: comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate. ( Bardin, C; Brouard, A; Kuntz, D; Lioté, F; Liou, A; Terrier, JL, 1992) |
| "Osteoporosis is a public health scourge that is usually eminently preventable." | 2.40 | Osteoporosis: prevention, diagnosis, and management. ( Deal, CL, 1997) |
| " With this in mind, the bioavailability of the drug has to be taken into account, particularly its gastrointestinal absorption which is dramatically enhanced if a plain non entericoated (EC) capsule is used, as compared to that of an EC tablet with the same face value." | 2.39 | Fluoride therapy of type I osteoporosis. ( Devogelaer, JP; Nagant de Deuxchaisnes, C, 1995) |
| "Women are the most common victims of involutional osteoporosis because of post-menopausal bone loss induced by oestrogenic deficit." | 2.38 | Osteoporosis. ( Devogelaer, JP; Nagant de Deuxchaisnes, C, 1993) |
| "Osteoporosis is a major public health problem." | 2.38 | Treatment of osteoporosis and Paget's disease. ( Nicholson, GC; Stewart, GO, 1991) |
| "Treatment with sodium fluoride increases bone density, but its effect on the incidence of fractures remains uncertain." | 2.38 | Osteoporosis. ( MacLennan, WJ, 1990) |
| "Osteoporosis is a metabolic bone disease characterized by an increased risk of fractures, especially hip, wrist and vertebral fractures." | 1.30 | [Osteoporosis: its diagnosis, its consequences]. ( Hardouin, P, 1997) |
| "Two cases are reported, both treated for postmenopausal osteoporosis with calcium, vitamin D and sodium fluoride for longer periods over many years, and with good effect on pain and tendency to lumbar vertebral body fracture." | 1.29 | [Fluorosis. Experiences based on two cases]. ( Duus, G; Johannessen, F; Tollefsen, I, 1995) |
| " The results of this study indicate that long-term administration of sodium fluoride may be detrimental to bone quality, at least as measured in non-loaded iliac crest trabecular bone." | 1.29 | [Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis]. ( Mosekilde, L; Richards, A; Søgaard, CH, 1995) |
| " Thus, it may be hypothesized that the high bone fluoride uptake is due to different individual responses from one patient to another concerning the bioavailability of the same dose of fluoride." | 1.29 | Relationship between bone fluoride content and histological evidence of calcification defects in osteoporotic women treated long term with sodium fluoride. ( Boivin, G; Chapuy, MC; Duriez, J; Flautre, B; Hardouin, P; Meunier, PJ, 1993) |
| "Forty seven women with postmenopausal osteoporosis and at least one but no more than four vertebral compression fractures received sequential and cyclical therapy with phosphorus and etidronate (p/etid)." | 1.28 | Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women. ( Anger, MS; Kowalski, L; McIntyre, DO; Miller, PD; Neal, BJ; Yanover, MJ, 1991) |
| "Osteoporosis is the most common metabolic bone disorder in the United States." | 1.28 | The prevention of osteoporosis. ( Levin, RM, 1991) |
| "003), suggesting that this difference in efficacy and tolerance is related to a better bioavailability of fluoride provided by MFP than by NaF." | 1.28 | Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. ( Chapuy, MC; Delmas, PD; Duboeuf, F; Dupuis, J; Meunier, PJ, 1990) |
| "Four other patients had stress fractures associated with trauma." | 1.28 | Fluoride-induced fractures: relation to osteogenic effect. ( Bayley, TA; Goodwin, S; Harrison, JE; Josse, RG; Murray, TM; Pritzker, KP; Strauss, A; Sturtridge, W; Vieth, R, 1990) |
| "We report on 61 women with postmenopausal osteoporosis who were treated with either plain sodium fluoride (NaF) capsules or enteric-coated NaF tablets for 4 years, in whom possible therapeutic and toxic effects were monitored." | 1.28 | Fluoride treatment of postmenopausal osteoporosis: age, renal function, and other clinical factors in the osteogenic response. ( Bayley, TA; Budden, F; Chow, R; Harrison, JE; Josse, RG; Kandel, R; Laurier, L; Murray, TM; Pritzker, KP; Sturtridge, WC, 1990) |
| "76 years, were treated in the course of one year with sodium fluoride (Fluosen) in a dose of 45 mg/24 h in combination with calcium gluconate (2 g/24 h) and oil solution of vit D2 (2 mg/week)." | 1.28 | [Treatment of patients with postmenopausal and steroid-induced osteoporosis using sodium fluoride combined with vitamin D2 and calcium gluconate]. ( Andreeva, M; Diankova, L; Kamenova, P; Khristova, D; Todorova, S; Tsachev, K, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (2.53) | 18.7374 |
| 1990's | 66 (83.54) | 18.2507 |
| 2000's | 10 (12.66) | 29.6817 |
| 2010's | 1 (1.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acerbo, AS | 1 |
| Kwaczala, AT | 1 |
| Yang, L | 1 |
| Judex, S | 1 |
| Miller, LM | 1 |
| Celi, M | 1 |
| Letizia, C | 1 |
| Ragno, A | 1 |
| Minisola, S | 1 |
| D'Erasmo, E | 1 |
| Mazzuoli, GF | 1 |
| Morabito, N | 1 |
| Gaudio, A | 1 |
| Lasco, A | 1 |
| Vergara, C | 1 |
| Tallarida, F | 1 |
| Crisafulli, G | 1 |
| Trifiletti, A | 1 |
| Cincotta, M | 1 |
| Pizzoleo, MA | 1 |
| Frisina, N | 1 |
| Galus, K | 1 |
| Tollefsen, I | 1 |
| Duus, G | 1 |
| Johannessen, F | 1 |
| Pak, CY | 11 |
| Sakhaee, K | 8 |
| Adams-Huet, B | 4 |
| Piziak, V | 3 |
| Peterson, RD | 2 |
| Poindexter, JR | 2 |
| Ettinger, B | 1 |
| Søgaard, CH | 1 |
| Mosekilde, L | 2 |
| Richards, A | 1 |
| Fratzl, P | 1 |
| Roschger, P | 1 |
| Eschberger, J | 1 |
| Abendroth, B | 1 |
| Klaushofer, K | 1 |
| Breslau, NA | 1 |
| Boyd, P | 1 |
| Herzog, J | 1 |
| Heard-Sakhaee, A | 1 |
| Haynes, S | 1 |
| Reisch, JS | 1 |
| Heaney, RP | 1 |
| Riggs, BL | 3 |
| O'Fallon, WM | 3 |
| Lane, A | 1 |
| Hodgson, SF | 2 |
| Wahner, HW | 2 |
| Muhs, J | 1 |
| Chao, E | 1 |
| Melton, LJ | 3 |
| Kleerekoper, M | 4 |
| Mendlovic, DB | 1 |
| Boivin, G | 1 |
| Duriez, J | 1 |
| Chapuy, MC | 2 |
| Flautre, B | 1 |
| Hardouin, P | 2 |
| Meunier, PJ | 4 |
| Antich, PP | 3 |
| Gonzales, J | 2 |
| Anderson, J | 1 |
| Rubin, C | 2 |
| Devogelaer, JP | 2 |
| Nagant de Deuxchaisnes, C | 2 |
| Bell, NH | 2 |
| Licata, A | 1 |
| Johnston, C | 1 |
| Rubin, B | 1 |
| Bonnick, S | 1 |
| Graham, H | 1 |
| Ballard, J | 1 |
| Berger, R | 1 |
| Fears, W | 1 |
| Breslau, N | 1 |
| Rubin, CD | 2 |
| Zerwekh, JE | 5 |
| Isenbarger, DW | 1 |
| Chapin, BL | 1 |
| Singer, FR | 1 |
| Deal, CL | 1 |
| Dempster, DW | 1 |
| Padalino, P | 1 |
| Gibaldi, M | 1 |
| Egan, KS | 1 |
| Golden, BD | 1 |
| Miller, P | 1 |
| Lukert, B | 1 |
| Broy, S | 1 |
| Civitelli, R | 1 |
| Fleischmann, R | 1 |
| Gagel, R | 1 |
| Khosla, S | 1 |
| Lucas, M | 1 |
| Maricic, M | 1 |
| Pacifici, R | 1 |
| Recker, R | 1 |
| Sarran, HS | 1 |
| Short, B | 1 |
| Short, MJ | 1 |
| Sebert, JL | 1 |
| Reginster, JY | 1 |
| Briancon, D | 1 |
| Appelboom, T | 1 |
| Netter, P | 1 |
| Loeb, G | 1 |
| Rouillon, A | 1 |
| Barry, S | 1 |
| Evreux, JC | 1 |
| Avouac, B | 1 |
| Marchandise, X | 1 |
| Villani, P | 1 |
| Brondino-Riquier, R | 1 |
| Bouvenot, G | 1 |
| Balena, R | 1 |
| Foldes, JA | 1 |
| Shih, MS | 1 |
| Rao, DS | 2 |
| Schober, HC | 1 |
| Parfitt, AM | 2 |
| Rigalli, A | 2 |
| Pera, L | 1 |
| Morosano, M | 1 |
| Masoni, A | 1 |
| Bocanera, R | 1 |
| Tozzini, R | 1 |
| Puche, RC | 2 |
| Alloatti, R | 1 |
| Blank, RD | 1 |
| Bockman, RS | 1 |
| Guañabens, N | 1 |
| Farrerons, J | 1 |
| Perez-Edo, L | 1 |
| Monegal, A | 1 |
| Renau, A | 1 |
| Carbonell, J | 1 |
| Roca, M | 1 |
| Torra, M | 1 |
| Pavesi, M | 1 |
| Haguenauer, D | 1 |
| Welch, V | 1 |
| Shea, B | 1 |
| Tugwell, P | 1 |
| Wells, G | 1 |
| Ringe, JD | 1 |
| Rosen, CJ | 1 |
| Bilezikian, JP | 1 |
| Genant, HK | 1 |
| Li, J | 1 |
| Gutteridge, DH | 1 |
| Stewart, GO | 2 |
| Prince, RL | 1 |
| Price, RI | 1 |
| Retallack, RW | 1 |
| Dhaliwal, SS | 1 |
| Stuckey, BG | 1 |
| Drury, P | 1 |
| Jones, CE | 1 |
| Faulkner, DL | 1 |
| Kent, GN | 1 |
| Bhagat, CI | 1 |
| Nicholson, GC | 2 |
| Jamrozik, K | 1 |
| Compston, J | 1 |
| Prior, J | 1 |
| Gottschalk, F | 1 |
| Sambrook, P | 1 |
| Marx, CW | 1 |
| Dailey, GE | 1 |
| Cheney, C | 1 |
| Vint, VC | 1 |
| Muchmore, DB | 1 |
| Pouillès, JM | 2 |
| Trémollières, F | 2 |
| Ribot, C | 2 |
| Lioté, F | 1 |
| Bardin, C | 1 |
| Liou, A | 1 |
| Brouard, A | 1 |
| Terrier, JL | 1 |
| Kuntz, D | 1 |
| Hesch, RD | 1 |
| Rittinghaus, EF | 1 |
| Causse, E | 1 |
| Louvet, JP | 1 |
| Peterson, EL | 1 |
| Nelson, DA | 1 |
| Phillips, E | 1 |
| Schork, MA | 1 |
| Tilley, BC | 1 |
| Miller, PD | 1 |
| Neal, BJ | 1 |
| McIntyre, DO | 1 |
| Yanover, MJ | 1 |
| Anger, MS | 1 |
| Kowalski, L | 1 |
| Levin, RM | 1 |
| Kuska, J | 1 |
| Wiecek, A | 1 |
| Czech, U | 1 |
| Minne, HW | 1 |
| Stone, MD | 1 |
| Hosking, DJ | 1 |
| Gips, S | 1 |
| Cohen, L | 1 |
| Hardoff, R | 1 |
| Smith, R | 1 |
| Weryha, G | 1 |
| Aghassian, C | 1 |
| Morel, J | 1 |
| Leclère, J | 1 |
| Hartemann, P | 1 |
| Falch, JA | 1 |
| Gautvik, KM | 1 |
| Seymour, DG | 1 |
| Day, JJ | 1 |
| Pathy, MS | 1 |
| Lindsay, R | 1 |
| Delmas, PD | 1 |
| Dupuis, J | 1 |
| Duboeuf, F | 1 |
| Bayley, TA | 2 |
| Harrison, JE | 2 |
| Murray, TM | 2 |
| Josse, RG | 2 |
| Sturtridge, W | 1 |
| Pritzker, KP | 2 |
| Strauss, A | 1 |
| Vieth, R | 1 |
| Goodwin, S | 1 |
| Sturtridge, WC | 1 |
| Chow, R | 1 |
| Budden, F | 1 |
| Laurier, L | 1 |
| Kandel, R | 1 |
| Bang, S | 1 |
| Baud, CA | 1 |
| Reeve, J | 1 |
| Davies, UM | 1 |
| Hesp, R | 1 |
| McNally, E | 1 |
| Katz, D | 1 |
| Todorova, S | 1 |
| Diankova, L | 1 |
| Andreeva, M | 1 |
| Khristova, D | 1 |
| Tsachev, K | 1 |
| Kamenova, P | 1 |
| MacLennan, WJ | 1 |
| Chao, EY | 1 |
| Muhs, JM | 1 |
| Cedel, SL | 1 |
| Hodsman, AB | 1 |
| Drost, DJ | 1 |
| Farley, SM | 1 |
| Libanati, CR | 1 |
| Odvina, CV | 1 |
| Smith, L | 1 |
| Eliel, L | 1 |
| Wakley, GK | 1 |
| Kilcoyne, R | 1 |
| Schulz, EE | 1 |
| Baylink, DJ | 1 |
26 reviews available for sodium fluoride and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
[Prevention and treatment of osteoporosis].
Topics: Absorptiometry, Photon; Anticholesteremic Agents; Bone Density; Bone Density Conservation Agents; Ca | 2005 |
Sodium fluoride therapy of postmenopausal osteoporosis.
Topics: Aged; Bone and Bones; Female; Humans; Osteoblasts; Osteoporosis, Postmenopausal; Sodium Fluoride; Sp | 1993 |
Osteoporosis.
Topics: Accidental Falls; Age Factors; Aged; Bone Density; Calcitonin; Calcium, Dietary; Cost of Illness; Di | 1993 |
Fluoride therapy of type I osteoporosis.
Topics: Aged; Biological Availability; Clinical Trials as Topic; Female; Humans; Male; Osteoporosis; Osteopo | 1995 |
Sustained-release sodium fluoride in the management of established postmenopausal osteoporosis.
Topics: Biological Availability; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Female; H | 1997 |
Osteoporosis. Current pharmacologic options for prevention and treatment.
Topics: Calcitonin; Diphosphonates; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mortality; Oste | 1997 |
Slow-release sodium fluoride in osteoporosis.
Topics: Female; Fluorides, Topical; Humans; Osteoporosis, Postmenopausal; Sodium Fluoride | 1996 |
Osteoporosis: prevention, diagnosis, and management.
Topics: Bone Density; Calcitonin; Diphosphonates; Drug Therapy, Combination; Estrogen Replacement Therapy; F | 1997 |
Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis.
Topics: Alendronate; Bone Density; Bone Remodeling; Bone Resorption; Female; Humans; Osteoporosis, Postmenop | 1997 |
Prevention and treatment of osteoporosis: does the future belong to hormone replacement therapy?
Topics: Alendronate; Alzheimer Disease; Calcitonin; Calcium; Coronary Disease; Diphosphonates; Endometrial N | 1997 |
The prevention and treatment of osteoporosis.
Topics: Adult; Aged; Calcitonin; Estrogen Replacement Therapy; Etidronic Acid; Female; Humans; Middle Aged; | 1998 |
Management of postmenopausal osteoporosis for primary care.
Topics: Absorptiometry, Photon; Biomarkers; Bone Density; Calcitonin; Diphosphonates; Estrogen Replacement T | 1998 |
A review of clinical trials of therapies for osteoporosis using fracture as an end point.
Topics: Calcitonin; Diphosphonates; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Male; Ost | 1999 |
Fluoride for treating postmenopausal osteoporosis.
Topics: Bone Density; Female; Fluorides; Fractures, Bone; Humans; Osteoporosis, Postmenopausal; Phosphates; | 2000 |
Past and future of anabolic agents.
Topics: Animals; Calcium; Female; Fluorides; Fractures, Bone; Human Growth Hormone; Humans; Insulin-Like Gro | 2000 |
Clinical review 123: Anabolic therapy for osteoporosis.
Topics: Drug Therapy, Combination; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Osteo | 2001 |
Mechanisms of bone loss and gain in untreated and treated osteoporosis.
Topics: Bone and Bones; Bone Remodeling; Bone Resorption; Calcification, Physiologic; Female; Humans; Osteop | 2002 |
Choice of drugs for postmenopausal osteoporosis.
Topics: Adult; Calcitonin; Calcium, Dietary; Child; Diphosphonates; Estrogens; Female; Humans; Middle Aged; | 1992 |
Calcitriol and postmenopausal osteoporosis.
Topics: Anabolic Agents; Bone Density; Calcitriol; Calcium, Dietary; Estrogen Replacement Therapy; Etidronic | 1992 |
[Conclusive evaluation of osteoporosis therapy with fluorides].
Topics: Bone Density; Dose-Response Relationship, Drug; Female; Fluorides; Fractures, Spontaneous; Humans; O | 1991 |
Treatment of osteoporosis and Paget's disease.
Topics: Calcitonin; Calcium, Dietary; Diphosphonates; Estrogens; Female; Glucocorticoids; Humans; Osteitis D | 1991 |
[Involutional osteoporosis--pathogenesis, diagnosis, prevention and therapy].
Topics: Aged; Bone Density; Bone Resorption; Calcium, Dietary; Estrogen Replacement Therapy; Female; Humans; | 1991 |
Treatment of osteoporosis: current and future.
Topics: Aged; Estrogen Replacement Therapy; Etidronic Acid; Female; Humans; Middle Aged; Osteoporosis, Postm | 1991 |
New treatments for osteoporosis.
Topics: Bone Density; Bone Development; Bone Resorption; Drug Administration Schedule; Etidronic Acid; Femal | 1990 |
[The treatment of vertebral osteoporosis. Use of sodium fluoride and sodium monofluorophosphate in combination with calcium].
Topics: Calcium; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorides; Humans; Middle Aged | 1990 |
Osteoporosis.
Topics: Aged; Anabolic Agents; Calcium; Combined Modality Therapy; Estrogen Replacement Therapy; Female; Hum | 1990 |
23 trials available for sodium fluoride and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis.
Topics: Alkaline Phosphatase; Bone Density; Bone Resorption; Calcium; Diphosphonates; Drug Therapy, Combinat | 2003 |
Sodium fluoride makes headway in osteoporosis study.
Topics: Bone Density; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Sodium Fluoride; Spinal Fra | 1995 |
Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antacids; Body Height; Bone Density; Citrates; Citric Acid; Delayed-Action | 1995 |
Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle x-ray-scattering study.
Topics: Adult; Aged; Aged, 80 and over; Biomechanical Phenomena; Biopsy; Bone Density; Bone Diseases; Calcin | 1994 |
Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial.
Topics: Aged; Aged, 80 and over; Bone Density; Citrates; Citric Acid; Delayed-Action Preparations; Drug Admi | 1994 |
Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis.
Topics: Aged; Bone Density; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Lumbar Vert | 1994 |
Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
Topics: Bone Density; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Oste | 1996 |
The effect of intermittent slow-release sodium fluoride and continuous calcium citrate therapy on calcitropic hormones, biochemical markers of bone metabolism, and blood chemistry in postmenopausal osteoporosis.
Topics: Alkaline Phosphatase; Antioxidants; Biomarkers; Bone Remodeling; Bone Resorption; Calcitriol; Calciu | 1997 |
Influence of fracture criteria on the outcome of a randomized trial of therapy.
Topics: Aged; Anthropometry; Female; Fractures, Spontaneous; Humans; Lumbar Vertebrae; Middle Aged; Osteopor | 1998 |
Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
Topics: Aged; Bone Density; Calcium; Double-Blind Method; Drug Therapy, Combination; Ergocalciferols; Female | 1998 |
Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone.
Topics: Aged; Bone and Bones; Bone Remodeling; Calcification, Physiologic; Calcium; Dose-Response Relationsh | 1998 |
In postmenopausal osteoporosis the bone increasing effect of monofluorophosphate is not dependent on serum fluoride.
Topics: Bone Density; Female; Fluorides; Fluorides, Topical; Fluorine; Humans; Middle Aged; Osteoporosis, Po | 1999 |
Measurement of total and diffusible serum fluoride.
Topics: Aged; Blood Proteins; Diffusion; Electrodes; Fasting; Female; Fluorides; Humans; Middle Aged; Osteop | 1999 |
Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3 year trial.
Topics: Administration, Oral; Aged; Bone Density; Etidronic Acid; Female; Humans; Middle Aged; Osteoporosis, | 2000 |
Past and future of anabolic agents.
Topics: Animals; Calcium; Female; Fluorides; Fractures, Bone; Human Growth Hormone; Humans; Insulin-Like Gro | 2000 |
Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis.
Topics: Aged; Ambulatory Care; Blood Cell Count; Bone Density; Calcium; Calcium Citrate; Cholecalciferol; Co | 2001 |
A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fra
Topics: Adult; Aged; Anthropometry; Body Height; Bone Density; Calcium; Dose-Response Relationship, Drug; Dr | 2002 |
Bioavailability of fluoride in postmenopausal women: comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate.
Topics: Aged; Biological Availability; Calcium Carbonate; Drug Combinations; Drug Evaluation; Female; Fluori | 1992 |
A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis.
Topics: Aged; Double-Blind Method; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Sodium Fluorid | 1991 |
[The treatment of vertebral osteoporosis. Use of sodium fluoride and sodium monofluorophosphate in combination with calcium].
Topics: Calcium; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorides; Humans; Middle Aged | 1990 |
Sodium fluoride: too late and too toxic for the elderly osteoporotic patient? Additional comments.
Topics: Aged; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Sodium Fluoride | 1990 |
Effect of intermittent therapy with a slow-release fluoride preparation.
Topics: Bone Density; Calcitriol; Delayed-Action Preparations; Drug Administration Schedule; Female; Fractur | 1990 |
Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
Topics: Aged; Bone Density; Calcium; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fractures, | 1990 |
32 other studies available for sodium fluoride and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Alterations in collagen and mineral nanostructure observed in osteoporosis and pharmaceutical treatments using simultaneous small- and wide-angle X-ray scattering.
Topics: Alendronate; Animals; Bone and Bones; Bone Density Conservation Agents; Collagen; Disease Models, An | 2014 |
[Effects of the combined raloxifene-sodium fluoride therapy on bone mass and bone turnover in women with postmenopausal osteoporosis].
Topics: Analysis of Variance; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Case-Control S | 2002 |
[Fluorosis. Experiences based on two cases].
Topics: Aged; Bone and Bones; Diagnosis, Differential; Female; Fluorides, Topical; Humans; Osteoporosis, Pos | 1995 |
Postmenopausal osteoporosis.
Topics: Aged; Bone and Bones; Bone Density; Bone Development; Bone Resorption; Calcitonin; Calcium; Diphosph | 1994 |
[Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis].
Topics: Aged; Biomechanical Phenomena; Bone and Bones; Bone Density; Female; Humans; Ilium; Longitudinal Stu | 1995 |
Fluoride and osteoporosis.
Topics: Delayed-Action Preparations; Female; Humans; Osteoporosis, Postmenopausal; Sodium Fluoride; Spinal F | 1994 |
Relationship between bone fluoride content and histological evidence of calcification defects in osteoporotic women treated long term with sodium fluoride.
Topics: Aged; Bone and Bones; Calcinosis; Calcium; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal | 1993 |
Measurement of intrinsic bone quality in vivo by reflection ultrasound: correction of impaired quality with slow-release sodium fluoride and calcium citrate.
Topics: Analysis of Variance; Bone and Bones; Bone Density; Citrates; Citric Acid; Delayed-Action Preparatio | 1993 |
Fluoride: the verdict is in, but the controversy lingers.
Topics: Female; Fluorides, Topical; Humans; Osteoporosis, Postmenopausal; Sodium Fluoride | 1996 |
[Osteoporosis: its diagnosis, its consequences].
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Bone Resorption; Calcium, Dietary; Diphosphonates; | 1997 |
[Fragility of scientifically acquired data. The example of fluoride salts in osteoporosis].
Topics: Clinical Trials as Topic; Evidence-Based Medicine; Female; Humans; Osteoporosis, Postmenopausal; Rep | 1998 |
Lack of deleterious effect of slow-release sodium fluoride treatment on cortical bone histology and quality in osteoporotic patients.
Topics: Adult; Aged; Bone Density; Bone Remodeling; Citrates; Citric Acid; Delayed-Action Preparations; Drug | 1992 |
Do estrogens improve bone mineral density in osteoporotic women over age 65?
Topics: Absorptiometry, Photon; Aged; Bone Density; Drug Synergism; Drug Therapy, Combination; Estrogen Repl | 1992 |
[Comparative effects of sodium fluoride and hormonal replacement therapy on bone metabolism in osteoporotic women with high fracture risk. Results of monitoring for 2 years].
Topics: Age Factors; Aged; Bone and Bones; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therap | 1992 |
Fluoride therapy in postmenopausal osteopenic women: effect on vertebral and femoral bone density and prediction of bone response.
Topics: Aged; Bone Density; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopaus | 1991 |
Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women.
Topics: Aged; Bone Density; Drug Administration Schedule; Drug Therapy, Combination; Etidronic Acid; Female; | 1991 |
The prevention of osteoporosis.
Topics: Aged; Back Pain; Bone Density; Calcitonin; Calcium, Dietary; Diphosphonates; Estradiol Congeners; Fe | 1991 |
Fluoride bioavailability from immediate-release sodium fluoride with calcium carbonate compared with slow-release sodium fluoride with calcium citrate.
Topics: Aged; Biological Availability; Calcium Carbonate; Citrates; Citric Acid; Delayed-Action Preparations | 1991 |
[Can sodium fluoride still be administered today in the treatment of osteoporosis?].
Topics: Female; Fractures, Spontaneous; Humans; Middle Aged; Osteoporosis, Postmenopausal; Sodium Fluoride | 1991 |
'Stress fracture' in osteoporosis treated with sodium fluoride.
Topics: Calcaneus; Diagnosis, Differential; Female; Fractures, Stress; Humans; Middle Aged; Osteoporosis, Po | 1991 |
Osteoporosis after 60.
Topics: Aged; Aged, 80 and over; Bone Density; Etidronic Acid; Female; Humans; Middle Aged; Osteoporosis, Po | 1990 |
[Bone complications of fluorotherapy: influence of androgen deficiency].
Topics: Androgens; Bone Diseases; Female; Fractures, Stress; Humans; Middle Aged; Osteoporosis, Postmenopaus | 1990 |
[News on treatment of osteoporosis with fluoride].
Topics: Aged; Female; Humans; Osteoporosis, Postmenopausal; Sodium Fluoride | 1990 |
Fluoride and bone--quantity versus quality.
Topics: Calcium; Estrogens; Female; Fractures, Bone; Humans; Osteoporosis, Postmenopausal; Sodium Fluoride | 1990 |
Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
Topics: Aged; Bone Density; Calcium; Drug Therapy, Combination; Female; Fluorides; Fractures, Spontaneous; H | 1990 |
Fluoride-induced fractures: relation to osteogenic effect.
Topics: Aged; Drug Therapy, Combination; Female; Femoral Neck Fractures; Fractures, Bone; Fractures, Stress; | 1990 |
Fluoride treatment of postmenopausal osteoporosis: age, renal function, and other clinical factors in the osteogenic response.
Topics: Aged; Aging; Bone Density; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Kidney; Middle | 1990 |
Topographical distribution of fluoride in iliac bone of a fluoride-treated osteoporotic patient.
Topics: Aged; Aged, 80 and over; Biopsy; Female; Humans; Ilium; Osteoporosis, Postmenopausal; Radiography; S | 1990 |
Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
Topics: Bone Density; Calcium; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Fractures, B | 1990 |
[Treatment of patients with postmenopausal and steroid-induced osteoporosis using sodium fluoride combined with vitamin D2 and calcium gluconate].
Topics: Adrenal Cortex Hormones; Adult; Aged; Body Height; Calcium Gluconate; Chronic Disease; Drug Evaluati | 1990 |
The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride.
Topics: Absorptiometry, Photon; Aged; Bone Density; Calcium, Dietary; Female; Humans; Middle Aged; Osteoporo | 1989 |
Efficacy of long-term fluoride and calcium therapy in correcting the deficit of spinal bone density in osteoporosis.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Bone Density; Calcium; Female; Humans; Lumbar Verte | 1989 |